Marc S. Ullman’s practice includes representation of clients on issues relating to FDA compliance, including labels, labeling, claims and good manufacturing practices. He has also represented clients in a number of complex adversarial proceedings with the FDA relating to the scope of the agency’s powers under the Dietary Supplement Health and Educational Act of 1994 and its abilities to seek remedies such as consumer restitution as well as counseling clients on general litigation related issues and most recently on complex legal issues of concern to the emerging hemp trade in the United States.

Marc’s expertise includes guiding clients through FDA’s New Dietary Ingredient Notification (NDI) Process and counseling on the issues involved in achieving status as Generally Recognized as Safe (GRAS) as a prerequisite for ingredient use in food products. He also speaks frequently on these and other matters at various events. Marc is an instructor at a well-known training seminar on Good Manufacturing Practices for Dietary Supplements offered several times a year across the country and has spoken at a number of the Annual Meetings of the New York State Bar Association.